Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Canal

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2010
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancerSébastien Vergez, Jean-Pierre Delord, Fabienne Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Individual adaptive dosing of topotecan in ovarian cancerAshraf Montazeri, Stéphane Culine, Brigitte Laguerre, et al.
Head & Face Medicine|April 24, 2020
Incorrect measurements and misleading conclusions in the article "Comparison of the efficacy of tooth alignment among lingual and labial brackets: an in vitro study"Dirk Wiechmann, Hans-Peter Bantleon, Birte Melsen, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2010
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancerSébastien Vergez, Jean-Pierre Delord, Fabienne Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Individual adaptive dosing of topotecan in ovarian cancerAshraf Montazeri, Stéphane Culine, Brigitte Laguerre, et al.
Head & Face Medicine|April 24, 2020
Incorrect measurements and misleading conclusions in the article "Comparison of the efficacy of tooth alignment among lingual and labial brackets: an in vitro study"Dirk Wiechmann, Hans-Peter Bantleon, Birte Melsen, et al.
Pageof 3